USA - NYSEARCA:CMD -
The current stock price of CMD is 80.37 null. In the past month the price decreased by -9.48%. In the past year, price increased by 60.13%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.93B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.12 | 194.84B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.28 | 149.85B | ||
| SYK | STRYKER CORP | 29.34 | 144.13B | ||
| MDT | MEDTRONIC PLC | 16.9 | 119.89B | ||
| BDX | BECTON DICKINSON AND CO | 12.92 | 52.83B | ||
| IDXX | IDEXX LABORATORIES INC | 52.96 | 50.88B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.02 | 48.32B | ||
| RMD | RESMED INC | 27.02 | 37.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.98 | 36.13B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.22 | 26.24B | ||
| DXCM | DEXCOM INC | 40 | 26.67B |
Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. The company is headquartered in Little Falls, New Jersey and currently employs 3,669 full-time employees. The firm's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The firm's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The firm's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The firm offers a range of filters utilizing hollow fiber membrane technology.
Cantel Medical
150 Clove Rd
Little Falls NEW JERSEY 07424 US
CEO: George L. Fotiades
Employees: 3669.0
Phone: 19738907220.0
Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. The company is headquartered in Little Falls, New Jersey and currently employs 3,669 full-time employees. The firm's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The firm's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The firm's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The firm offers a range of filters utilizing hollow fiber membrane technology.
The current stock price of CMD is 80.37 null. The price decreased by -1.18% in the last trading session.
Cantel Medical (CMD) has a dividend yield of 0.13%. The yearly dividend amount is currently 0.11.
CMD has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Cantel Medical (CMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The PE ratio for Cantel Medical (CMD) is 48.42. This is based on the reported non-GAAP earnings per share of 1.66 and the current share price of 80.37 null.
The next ex-dividend date for Cantel Medical (CMD) is January 16, 2020.
ChartMill assigns a technical rating of 5 / 10 to CMD. When comparing the yearly performance of all stocks, CMD is one of the better performing stocks in the market, outperforming 70.58% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CMD. CMD has an average financial health and profitability rating.
Over the last trailing twelve months CMD reported a non-GAAP Earnings per Share(EPS) of 1.6600000000000001. The EPS decreased by -29.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.57% | ||
| ROA | 2.56% | ||
| ROE | 6.37% | ||
| Debt/Equity | 0.9 |
4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37.
For the next year, analysts expect an EPS growth of 82.92% and a revenue growth 17.48% for CMD